Tower Research Capital (TRC)’s AdvisorShares Psychedelics ETF PSIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6
Closed -$78 6079
2023
Q4
$78 Buy
+6
New +$85 ﹤0.01% 5731
2022
Q4
Sell
-74
Closed -$2K 6262
2022
Q3
$2K Buy
+74
New +$2.36K ﹤0.01% 5602

Other funds holding PSIL

Tower Research Capital (TRC)'s PSIL Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of AdvisorShares Psychedelics ETF (PSIL) in Q1 2024, closing a stake of 6 shares — an estimated $78 sold.

Tower Research Capital (TRC) first reported a position in PSIL in Q3 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 13 funds tracked by Wall St. Rank hold PSIL as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining AdvisorShares Psychedelics ETF position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6 AdvisorShares Psychedelics ETF shares in Q1 2024, an estimated $78.
  • Tower Research Capital (TRC) first reported a position in AdvisorShares Psychedelics ETF in Q3 2022 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s AdvisorShares Psychedelics ETF position peaked at $2K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held AdvisorShares Psychedelics ETF as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.